OmniTier says its new tech platform has big implications for the spread of personalized medicine.
The fund has invested $500K so far; Ambient Clinical Analytics is the latest recipient.
The platform allows health researchers to bring zebrafish embryos to life after freezing.
The vision sees ‘BRT’ circulator connecting Mayo Clinic with 6,000 new parking spaces.
A new 13-member research team will analyze the relationship between gut bacteria and colon cancer.
Proceeds from the Rochester loan will be used to expand operations, create jobs and develop a new product, identified as “on field-mixed reality training.”
The National Science Foundation sees commercialization potential in the University of Minnesota’s “synthetic incompatibility” process that can target certain mosquito populations.
The University of Minnesota’s Office for Technology Commercialization is offering the algorithm for licensing opportunities.
Three proposals would build or renovate 529 guest rooms around Mayo Clinic.
Miromatrix, Superior Organoid, and MNPHARM each landed $100,000 regenerative medicine awards.
The deal will seek to commercialize the Preparing Heart and Mind educational app for parents of babies with heart defects.
A collaboration between Mayo and Exact Sciences is yielding accurate blood DNA tests for treatable cases.
Noaber Foundation led a $1.5 million venture round for the digital health platform.
The new printer has been proven capable of printing out skin cells to repair wounds in tests on mice.
Magenta Therapeutics looks to expand the amount of stem cells for marrow transplants.
Cytox Ltd. will use bio-samples from Mayo to develop an algorithm predicting genetic vulnerability.
The institute will focus on treatments for “cellular senescence” to slow the aging process.
Partnering company MRI Interventions says the next step will be filing a 510(k), which will come in the third quarter.
It will play a key role in the U.S. “All of Us” effort to advance individualized medicine.
Its Office of Technology and Commercialization is up for a GUV Award in London.
IPO documents reveal potential of clinic’s collaboration with Evelo Biosciences.
Powered by the Mayo Clinic’s AI, research claims it can read blood potassium with a touch.
Method uses newly-discovered molecular targets to make deadly tumors more vulnerable.
Medicool Technologies is looking to halt atrial fibrillations painlessly with a new, novel implant.
San Francisco anti-aging firm seeks $85 million for clinical trials using Mayo intelligence.
The shuttered 1920s theater will host ‘interim uses’ with a $1 million infusion.
Use of ‘liquid biopsies’ to track disease progression found to be feasible.
Thaddeus Medical is in line for $50K, while Hunhu Medical declared a loss in its report to the city.
The Rochester firm will hire up to 30 new workers as it completes a new headquarters build-out.
Their startup makes tool for fast-growing ‘mechanical thrombectomy’ procedures.
The incubator grad said it was making “remarkable progress” with its carpel tunnel surgery device.
A ‘dipstick’ test for urinary tract infections could one day be available in drugstores.
The follow-on investment in Helix's $200 million Series B round furthers Mayo’s goal to ‘democratize’ patient knowledge.
Massachusetts-based Hologic Inc. landed the U.S. rights for the University of Minnesota's 'Dexalytics' athletic performance software.
The mixed public-private effort with Vaccinex is aiming to bring about a treatment for intractable osteosarcoma.
Sonex Health of Rochester and Oculogics of Minneapolis land initial venture backing.
Stem cells from new automated platform in Florida could be used in Rochester.
RAEDI said its $1.5 million investment triggered $61 million in follow-on funding for local firms.
The development of 'cerebral organoids' from stem cells could impact the fight against Parkinson's disease.
Indiana-based Recovery Force makes microprocessor-controlled compression wraps.
Documents show the biotech incubator is seeking an 18,000-square-foot addition.
This is the second recent biotech investment from the young nonprofit.
A Phase I study has opened for non-Hodgkin lymphoma and multiple myeloma patients.
The Rochester-based health care provider and Veritas Genetics are launching an effort aimed at greatly extending WGS availability.
Neurodegenerative and liver disease are among the targets of Regenerative Medicine Minnesota.
A preclinical study between Mayo and collaborator Corindus Vascular Robotics will test a remote-controlled ‘telestenting’ system in face of likely cardiologist shortfall.
University professor Jerrold Vitek and the MnDRIVE program were key in approval for Parkinson’s treatment.
An Aussie firm with a Twin Cities headquarters is using circadian waves to identify depression types.
Workshops seek to give nurses tools to translate medtech ideas into reality.
Its deal with a Singapore firm backs an AI platform to predict cardiac health events.
Utilities say market forces and new technology, not politics,
have dethroned “King Coal.”
The deal came as Rochester laundry was purchased by Wisconsin company.
Using OptumLab data, researchers found some anticoagulants are easier on kidneys.
Fundraising comes after positive pre-clinical results for its AnestaGel product.
The new collaboration is seeking to develop a ‘microbiome’ drug for multiple sclerosis and rheumatoid arthritis.
The company is developing tech to greatly boost accuracy of common flu and malaria tests.
The method is aimed at those under 50 with hereditary high colorectal risk.
Earmarks $1.27 million for 2018 as initiative marks Discovery Square groundbreaking.
Masonic Cancer Center’s Chen and Tocagen Inc. announce ‘impressive’ results.
Apollo Endosurgery is touting an alternative to unpopular bariatric procedures.
Collaboration with United Therapeutics could include opening a similar facility in Rochester later on.
Two parties file patent application for unique self-centering catheter guide.
Medibio Ltd. also wrapped a nearly $14 million funding round this week.
The latest investment came from Southern Minnesota Initiative Foundation philanthropists.
The Center for Drug Design research team is readying "Sulfanegen" for clinical trials.
Second early-stage trial of ‘remyelinating’ drug candidate is close to completion.
New collaboration is clinic’s second in emerging personalized wellness field.
Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.
U of M spinoff has tech to analyze microbial communities for health, ag clients.
‘Minnesota Partnership’ seeks to develop pipeline of biotech startups, job creation.
Driven to Discover building is a step up in recruiting for on-site studies.
Recent U of M study shows 7.2 percent of rural hospitals have closed OB units.
Sanford Health will use the bioengineered bugs in a Sioux Falls cancer trial.
With deal in hand, developer Mortenson eyes fourth-quarter groundbreaking.
Aims for $1M in startup funding despite ‘sunset’ of state’s angel tax credit.
Updated plans for 10-acre campus site come as part of firm’s $62M IPO.
It is developing implantable system to detect, treat epileptic seizures.
Latest stake in AliveCor comes with effort to predict sudden cardiac arrest in kids.
OX2 Therapeutics touts method to ‘turn off’ protein that suppresses immune system.
Participates in $50 million Series B round for microbe-maker Evelo Biosciences.
The 60,000-square-foot medtech office building is an early step in Destination Medical Center effort.
The implantable device is backed by Italy’s Sorin Group and venture capital investors.
It was part of a $12 million Series A round led by Johnson & Johnson Innovation.
Rion LLC is developing tissue-growing biotech for cardiac, wound care markets.
2bPrecise LLC will use know-how in platform to fight familial hypercholesterolemia.
Funding pitched as key to school’s growing undergrad biology program.
Soundly touts airway-strengthening therapy as alternative to burdensome CPAP masks.
MnDRIVE snags funds for cancer research as sun sets on program to help startups.
MRI Interventions has development deal with clinic for new stroke therapies.
Move is part of new collaboration to develop system for treating arrhythmia.
Milken Institute report sites strength in income-generating licenses.
Backing comes from Canadian company in medical cannabis market.
Medtech’s move follows hires of locally based CEO and CFO.
Participates in $50M round for Magenta Therapeutics, forges strategic partnership.
Waterline Ventures, Bluestem Capital invest in patient care monitoring console.
Life sciences experts Hackett, Elias among school’s Innovation Award winners.
Roster includes researchers whose projects have commercialization potential.
Award comes as his Rochester startup sees demand spike for its patented tech.
Mayo-backed viral oncology firm graduating from clinic’s biz incubator.
Timing to take advantage of pending FDA ban on partially hydrogenated oils.
The two Minn. institutions combined for more than $500M in NIH funding last year.
Five life sciences research projects nearing market stage land MN-REACH funding.
Patent application filed on antibody used for individualized cancer treatments.
Health IT startup has $3.9M of total already in hand, SEC filing indicates.
Heart signal-processing firm teams with clinic on a 10-year collaboration.
Hennepin County researchers are advancing work that could help end the United State's burgeoning painkiller problem.
Bigger stake in AliveCor comes as firm rolls out expansion of detection software.
Proposal would make angel credit permanent and boost annual funding to $20 million.
Inventors said the new test can quickly determine if leukemia treatments are working.
Med device firm must meet shareholder’s equity requirements by March 20.
New East Bank building seeks to align curriculum with changing healthcare market.
It would allow therapies to bypass ‘blood-brain barrier’ to treat neuro conditions.
The Brothers Snyder laud hometown’s buzzing bio-business startup scene.
Startup Medicool targets irregular heartbeat with $250K NSF seed funding.
New drug candidate is latest tack in addressing hospital-acquired infections.
Detecting cancerous tumors from blood samples is the goal of Illumina and Exact Sciences.
StemoniX, Gila Therapeutics, MicroOptx lead pack in DEED’s annual accounting.
Xcede Technologies is ready to test a hemostatic patch for severe bleeding.
DayTwo’s individualized diet technology uses algorithm to predict glucose levels.
School commits $2.5M to navigate market path for BHB/M after 2010 startup bust.
New unit will provide corporate, government partners with simplified path.
The company was tapped to play key role in Kite Pharma’s promising T-cell lymphoma candidate.
The team behind Cologuard is working to extend methods to more gastrointestinal cancers.
Initial client list includes Ridgeview Medical, Centra Health, and Medcan.
Brian Bischoff is working with UMN professors to unlock stem cell blood supply promise.
Backers say wet lab conversion could tap buzzing Southeast Minnesota startup scene.
Provides web-based tool to help hospitals reduce ‘adverse events.'
Jacksonville team’s latest describes drug treatment for frontotemporal dementia.
They say benefits from sequencing genomes can’t be widely applied without changes.
Based on Mayo ‘cell senescence’ research, San Francisco-based Unity Biotechnology rakes in $116 million financing.
Patent filed for ‘smart’ polymer that could have big implications for pharma pipelines.
Deal includes investment in Silicon Valley digital health start-up AliveCor.
Leaders discuss how they approach high-growth overseas markets for devices.
Leaders of Twin Cities’ CRVx, Rotation Medical talk strategy in a tough capital climate.
State-funded program focuses on biotech, other fields with commercialization promise.
Calyxt founder Dan Voytas is applying editing methods for non-GMO crop improvements.
Same lab recently announced a breakthrough in mouse modeling for ALS research.
MN-REACH grant moves cellular-level tumor probe closer to market.
Colorectal cancer test’s epic journey to market a case study for innovation.
Close ties cited between Chrono Therapeutics, Mayo’s Nicotine Dependence Center.
A focus on technology transfer at Mayo’s Transform 2016 conference.
Top researchers James Russell, Moses Rodriguez cited as inventors of virus tech platforms.
University, Fate Therapeutics on commercialization track for cutting-edge immunotherapy.
Anthony Cataldo of Oxis Biotech touts immunotherapies targeting lymphoma and leukemia.
Evelo Biosciences joins four others as investment, research dollars flow into field.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.
After launch of Unity Biotechnology, study links osteoarthritis to ‘senescent’ cells.
With ties to U of M and Mayo Clinic, the start-up seeks to build on state’s genomics expertise.
Assurex Health’s licensed tech taps fast-growing neuroscience genomics market.
Shoreview firm to ramp up availability of magnetic “sphincter” devices as insurers sign on.
LAgen Laboratories produces bioengineered retinal cells for pharma, others.
Unequal medical outcomes, treatment resulting in trillions of dollars in extra costs.
A new round of state grants recognize promising bio-businesses in an exploding industry.
A look at MN-REACH grant winners can provide some future market insight.
As early trials show promise, ‘serial biotech entrepreneur’ Steve Gorlin signs on.
Inventors include founders of Minnesota start-ups Zumbro Discovery and NeoChord.
Celyad will accelerate commercialization of the C-Cure stem cell therapy after Phase III results.
IRRRB grants $38,000 to BRTI and the Northshore Business Enterprise Center.
Blueprint Bio’s biomarker discovery platform taps personalized medicine momentum.
Florida-based TapImmune exercises option, readies Phase II trials for HER2/neu cancer immunotherapy platform.
A look at the Rochester clinic’s Top 10 National Institutes of Health awards.
Regenerative, individualized medicine researchers seem likely picks for new Rochester buildings.
The company has thus far eschewed venture capital.
The clinic was an early investor in the company.
The latest and most innovative patents coming out of the Rochester medical powerhouse.
Mayo Clinic is at the forefront of integrating medicine outside the physician’s office into the organization.
The tissue regeneration company is preparing for human testing.
The health care provider has a joint venture with Cancer Genetics Inc. that will roll out a genetic sequencing test to better personalize cancer treatment.
Exact Sciences is already using Mayo research to roll out an at-home colorectal cancer screening kit.
The company likes the control it maintains by soliciting investment from within.
The next frontier of cancer treatment could be vaccines.
Can the bacteria living inside provide untapped health benefits?
Researchers will scan football players’ brains to determine if a supplemental vitamin can boost enzymes in the brain.
Two DFLers propose spending millions to help the state compete with the likes of California and Massachusetts.
Magnetic resonance elastography (MRE) is proving better at diagnosing cases of nonalcoholic fatty liver disease.
The DMC project is expected to create 45,000 jobs. But where will they come from, and is there any place for them to live?
A collaboration between Mayo and HART is attempting to introduce a bioengineered organ implant system into the market.
The med-tech startup is testing a new platform for treating complex heart arrhythmia.
Industry insiders say the collaboration was made possible in part through the repeal of the medical device tax.
An experimental drug tested by the medical organization appears to inhibit a key enzyme within cancerous cells.
Researchers are hopeful that smaller, more efficient machines will aid in studying brain disorders and issues.
Ambient Clinical Analytics software going global in Philips’ patient monitoring devices.
Why technology previously transferred outside Minnesota is now more likely to remain in Rochester.
Costs of wind and solar energy have dropped, making renewable energy a viable option for many businesses.
Despite many critics, tax-increment financing districts are on the rise in Minnesota.
Anyone who feels their neighborhood lacks, say, a bakery, can post the idea on the website.
Town Hall Tap owners chose to build the restaurant at 48th and Chicago rather than in Northeast Minneapolis partly because of the looser 60/40 food-alcohol-sales ratio.